PRESENTATION TITLE
Surveillance Epidemiology and End Results Program (SEER):  What's New to Support Cancer Research
PRESENTER(S)
Lynne Schumacher-Penberthy, M.D., MPH
Associate Director Surveillance Research Program, (SRP, within the Division of Cancer Control and Population Sciences, (DCCPS), National Cancer Institute (NCI)

PRESENTER BIO

Dr. Lynne Penberthy is the Associate Director for the Surveillance Research Program (SRP), which is within the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). Dr. Penberthy obtained her MD from the University of Michigan and her MPH in epidemiology at Johns Hopkins. Dr. Penberthy’s career includes a surgical internship in Baltimore, Maryland, at the Sinai Hospital and a preventive medicine residency at Johns Hopkins University. After her residency, she completed her post-doctoral training in epidemiology with the CDC as an epidemic intelligence service (EIS) officer with the Commonwealth of Virginia. She is licensed to practice medicine in the state of Maryland.

Prior to her NCI appointment, Dr. Penberthy was the Director of Cancer Research Informatics and Services and Associate Professor of General Internal Medicine at the Virginia Commonwealth University Massey Cancer Center. She directed a team in the development of innovative software with the objectives of using existing data for clinical trials eligibility screening, automated capture of treatment data from oncology practice claims, and the extraction of clinical characteristics from various electronic medical records (EMR) components. Dr. Penberthy was also involved in biobanking and annotation of specimens using clinical data. She has 20 years of experience in cancer surveillance and automation using secondary data. Dr. Penberthy has worked on more than 20 grants and contracts as well as 31 publications related to using secondary data and/or informatics tools for cancer surveillance and clinical trials assessment.

VIEWING LOCATIONS
Zoom Registration Link

LEARNING OBJECTIVES

• Interpret the role of central cancer registries and SEER in supporting cancer research.
• Identify key aspects of SEER enhancements that extend the ability to support cancer research.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.